Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mamelok, Richard D.
28  Ergebnisse:
Personensuche X
?
1

Limited Systemic Exposure with Topical Glycopyrronium Tosyl..:

Pariser, David M. ; Lain, Edward L. ; Mamelok, Richard D...
Clinical Pharmacokinetics.  60 (2021)  5 - p. 665-676 , 2021
Link: https://doi.org/10.1007/..
 
?
2

A 44-Week Open-Label Study Evaluating Safety and Efficacy o..:

Glaser, Dee Anna ; Hebert, Adelaide A. ; Nast, Alexander...
American Journal of Clinical Dermatology.  20 (2019)  4 - p. 593-604 , 2019
Link: https://doi.org/10.1007/..
 
?
3

Topical glycopyrronium tosylate for the treatment of primar..:

Glaser, Dee Anna ; Hebert, Adelaide A. ; Nast, Alexander...
Journal of the American Academy of Dermatology.  80 (2019)  1 - p. 128-138.e2 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Open-Label Study (ARIDO) Evaluating Long-Term Safety of Top..:

Glaser, Dee Anna ; Hebert, Adelaide A ; Nast, Alexander...
SKIN The Journal of Cutaneous Medicine.  2 (2018)  - p. S40 , 2018
Link: https://doi.org/10.25251..
 
?
5

Design and Conduct Considerations for First‐in‐Human Trials:

Shen, Jie ; Swift, Brandon ; Mamelok, Richard...
Clinical and Translational Science.  12 (2018)  1 - p. 6-19 , 2018
Link: https://doi.org/10.1111/..
 
?
6

Comparison of the Pharmacokinetics of Ketorolac Tromethamin..:

Burdick, Michael ; Mamelok, Richard ; Hurliman, Michele...
Clinical Pharmacology in Drug Development.  6 (2017)  4 - p. 343-349 , 2017
Link: https://doi.org/10.1002/..
 
?
7

Open-Label Study (ARIDO) Evaluating Long-Term Safety of Top..:

Glaser, Dee Anna ; Hebert, Adelaide A ; Nast, Alexander...
SKIN The Journal of Cutaneous Medicine.  1 (2017)  - p. s95 , 2017
Link: https://doi.org/10.25251..
 
?
8

Effect of Renal and Hepatic Impairment on the Pharmacokinet..:

Nguyen, Linh ; Holland, Jaymes ; Ramies, David...
The Journal of Clinical Pharmacology.  56 (2016)  9 - p. 1130-1140 , 2016
Link: https://doi.org/10.1002/..
 
?
9

Evaluation of the effect of food and gastric pH on the sing..:

Nguyen, Linh ; Holland, Jaymes ; Mamelok, Richard...
The Journal of Clinical Pharmacology.  55 (2015)  11 - p. 1293-1302 , 2015
Link: https://doi.org/10.1002/..
 
?
10

The pharmacokinetics of mycophenolate mofetil in renal tran..:

Grinyó, Josep M. ; Ekberg, Henrik ; Mamelok, Richard D....
Nephrology Dialysis Transplantation.  24 (2009)  7 - p. 2269-2276 , 2009
Link: https://doi.org/10.1093/..
 
?
11

Mycophenolic Acid Exposure after Administration of Mycophen..:

Kuypers, Dirk R. ; Ekberg, Henrik ; Grinyó, Josep...
Clinical Pharmacokinetics.  48 (2009)  5 - p. 329-341 , 2009
Link: https://doi.org/10.2165/..
 
?
12

Pharmacokinetics, efficacy, and safety of mycophenolate mof..:

Nashan, Björn ; Saliba, Faouzi ; Durand, Francois...
Liver Transplantation.  15 (2009)  2 - p. 136-147 , 2009
Link: https://doi.org/10.1002/..
 
?
13

CYP3A5 genotype is not associated with a higher risk of acu..:

Hesselink, Dennis A. ; van Schaik, Ron H.N. ; van Agteren, Madelon...
Pharmacogenetics and Genomics.  18 (2008)  4 - p. 339-348 , 2008
Link: https://doi.org/10.1097/..
 
?
14

Pharmacokinetics of mycophenolate mofetil in stable pediatr..:

Lobritto, Steven J. ; Rosenthal, Philip ; Bouw, Rene...
Liver Transplantation.  13 (2007)  11 - p. 1570-1575 , 2007
Link: https://doi.org/10.1002/..
 
?
15

Time‐dependent clearance of mycophenolic acid in renal tran..:

Van Hest, Reinier M. ; Van Gelder, Teun ; Bouw, René...
British Journal of Clinical Pharmacology.  63 (2007)  6 - p. 741-752 , 2007
Link: https://doi.org/10.1111/..
 
1-15